Biochemical and genetic findings accumulated over the past decade have established that the condensation of eukaryotic DNA in chromatin functions not only to constrain the genome within the boundaries of the cell nucleus but also to suppress gene activity in a general manner. This genetic repression extends from the level of the nucleosome, the primary unit of chromatin organization, where coiling of DNA on the surface of the nucleosome core particle impedes access to the transcriptional apparatus, to the higher order folding of nucleosome arrays and the organization of silent regions of chromatin (for reviews see Refs. 1-6 and 105). Chromatin structure is inextricably linked to transcriptional regulation, and recent studies show how chromatin is perturbed so as to facilitate transcription (for reviews see Refs. [7] [8] [9] [10] [11] [12] . Here, we review the substantial advances in the identification of histone acetyltransferases and histone deacetylases, whose opposing activities establish the steady-state level of histone acetylation, and progress in studies of multicomponent systems that require energy for the process of nucleosome disruption.
Histone Acetylation
Since the early discovery of histone acetylation by Allfrey and colleagues (13) , this post-translation modification has been correlated with the processes of transcription and chromatin assembly. Acetylation occurs at specific lysines in the flexible N-terminal histone tails that protrude from the nucleosome surface (11, 14) . Hyperacetylation of histones is associated with transcriptional activity or the potential for activity, whereas histone hypoacetylation is correlated with transcriptionally silent chromatin and heterochromatin. Histone acetylation is also associated with the active deposition and maturation of newly assembled nucleosomes during DNA replication (for reviews see Refs. 14 and 15). Acetylation reduces the net positive charge of the histones and weakens interactions with DNA (16), inhibits the higher order folding of nucleosome arrays (17, 18) , and disrupts specific interactions with nonhistone regulators, as shown for the yeast silencer and repressor proteins Sir3 and Sir4 (19, 20) and Tup-1 (21).
Tetrahymena Histone Acetyltransferase A and Yeast Gcn5
In a convergence of biochemical and genetic studies, cloning of the p55 catalytic subunit of Tetrahymena nuclear (A-type) histone acetyltransferase (HAT) 1 revealed substantial sequence identity with yeast Gcn5, previously defined genetically as a transcriptional coactivator (22) . The catalytic domain of the Gcn5 HAT is required for coactivator function in vivo, providing a genetic link between histone modification and transcriptional activation (23) . As a human GCN5 homolog has been identified, this HAT is likely to be widely conserved (24, 25) . Bacterially expressed yeast Gcn5 protein acetylates free histone H3 strongly at lysine 14 and histone H4 weakly at lysines 8 and 16 (26) . However, unlike the native HAT A enzyme, recombinant Gcn5 cannot acetylate nucleosomal histones, implying that other subunits in the complex must influence its activity on chromatin. Genetic and biochemical studies reveal at least two interacting proteins, Ada2 and Ada3, that form a complex with Gcn5 (23, (27) (28) (29) . Binding of Ada2 to the activation domains of the transcriptional activators VP16 and Gcn4 in vitro suggests a mechanism by which promoter targeting of Gcn5 might be achieved (30, 31) .
P/CAF, p300/CBP, SAS, MOZ, and MOF
An increasing number of putative or demonstrated histone acetyltransferases have emerged in the past year. P/CAF (p300/CBP-associated factor) is a novel histone acetyltransferase isolated on the basis of sequence similarity to human and yeast Gcn5 (32) , which interacts with the highly related transcriptional coactivators p300/CBP. Like Gcn5, recombinant P/CAF has intrinsic HAT activity for free histones H3 and H4, but unlike Gcn5, P/CAF is also able to acetylate nucleosomal histone H3. p300/CBP (CREB-binding protein) is itself a histone acetyltransferase with no resemblance in sequence to the other acetyltransferases (33, 106) . The bacterially expressed p300/CBP protein is unique among HAT polypeptides in that it can acetylate all four core histones free in solution or when complexed in the nucleosome; acetylation on histone H4 occurs at lysines 5, 8, 12 , and 16, the same positions that are subject to acetylation in vivo (32) . p300 and CBP are known to physically interact with numerous transcription factors activated by signaling cascades, including CREB, c-Jun/v-Jun, Fos, and nuclear hormone receptors, and are also targets for the E1A oncoprotein (for a review see Ref. 34) . Whether histones are substrates of p300 in vivo remains to be determined.
The yeast SAS, human MOZ and Tip60, and fly MOF proteins constitute a different class of putative acetyltransferases, characterized by a ϳ300-amino acid region of significant similarity that contains a C2CH zinc finger motif and a subregion similar to HATs and other acetyltransferases (35) (36) (37) (38) . The biochemical properties or substrate specificities of these proteins involved in silencing (SAS), transcriptional activation (Tip60), leukemogenesis (MOZ), and dosage compensation (MOF) have not yet been described. Interestingly, recurrent translocation in a subtype of acute myeloid leukemia generates a novel fusion of MOZ with CBP, suggesting that the aberrant acetylation of histones or other chromosomal proteins could mediate leukemogenesis (36) . 
TAF250
TFIID, the general transcription factor complex of TBP (TATA-binding protein) and the associated TAF proteins, has been found to contain a HAT activity. Unique among the various TAFs, TAF II 250 alone or in the TFIID complex has both a serine kinase activity selective for RAP74 (a subunit of TFIIF) and a HAT activity (39, 40) . Like Gcn5, TAF II 250 preferentially acetylates free histone H3 over H4 and has little or no activity on nucleosomal histones (40) . The domain of TAF II 250 responsible for HAT activity maps to the central, conserved region and shows no obvious sequence similarity to other HATs. The finding of HAT activity in TAF II 250 implies that TFIID could contribute toward destabilizing nucleosomes over core promoter elements, although the physiological substrates of the HAT activity remain to be determined. TFIID may possess yet an another capacity for assisting nucleosome disorder. Portions of several TAFs (Drosophila TAF II 42 and TAF II 62) adopt a histone octamer-like substructure that might be employed as a histone octamer-like substructure, which could serve as a competitor for DNA binding with the core histones (41) (42) (43) .
Histone Deacetylases
In parallel with the identification of HAT enzymes, studies of histone deacetylase (HDAC) enzymes in human, yeast, and Drosophila have also advanced significantly. Affinity chromatography with the ligand trapoxin, a high affinity, irreversible inhibitor, resulted in the purification and cloning of a human deacetylase (44) composed of a catalytic subunit, HD-1, renamed HDAC1 (45) , and a tightly associated WD repeat protein, RbAp48. The sequence of the HDAC1 showed very strong sequence identity to yeast Rpd3, previously identified genetically to be necessary for full repression and activation of a subset of genes (46) . There are five members of the RPD3 family in yeast, two of which (HDA1 and RPD3) are components of the major histone deacetylase activities, which fractionate as 350-kDa (HDA) and 600-kDa (HDB) complexes (47, 48) .
As anticipated from the catalytic properties of the encoded proteins, deletions of the HDA1 and RPD3 genes strongly reduce HDA and HDB activities, leading to hyperacetylation of histones H3 and H4 in vivo. However, the phenotypes of these deletions are somewhat surprising, as they increase repression rather than increase activation of telomeric loci (48) . Similarly, mutation of a Drosophila homolog of RPD3 displays an enhancer of position effect variegation phenotype, suggesting that loss of wild-type Drosophila RPD3 function as a histone deacetylase leads to increased gene silencing (49) . These findings may perhaps be related to the acetylation of histone H4 at lysine 12, which is required for transcriptional silencing in yeast (50) and which is also associated with heterochromatin in Drosophila (51), despite net hypoacetylation.
More in line with the anticipated involvement of histone deacetylases in transcriptional repression is the physical association of the heteromeric Mad (Mxi1)/Max DNA binding repressors involved in controlling cell proliferation and differentiation with mammalian RPD3 homologs and with Sin3, a conserved transcriptional co-repressor genetically linked to yeast Rpd3 (45, 52) . Immunopurification studies also reveal additional, novel polypeptides associated with Sin3 and histone deacetylase in human cell extracts (54) . YY1, a mammalian sequence-specific transcription factor that can serve as a repressor binds directly to histone deacetylase (55) , and NCoR and SMRT, co-repressors for nuclear hormone receptors, interact with complexes containing mammalian Sin3 and histone deacetylase (53, 56, 57). Repression of meiotic genes by the yeast Ume6 protein also involves recruitment of a complex containing Sin3 and Rpd3 (58) . This literal explosion of new data provides strong support for a model of gene-specific repression by the recruitment of multicomponent, histone deacetylase complexes to target promoters.
ATP-dependent Nucleosome Remodeling Factors
SWI2/SNF2, Brm, and BRG1-A novel class of chromatin remodeling proteins has recently emerged whose activities are dependent on or associated with ATP hydrolysis (for reviews see Refs. 12, 59, 60, and 107). The prototype of this class, yeast SWI2/SNF2, was discovered in genetic screens as a positive transcriptional regulator of a limited set of yeast genes. SWI2/ SNF2 contains sequence motifs closely related to those found in DNA-stimulated ATPases/DNA helicases (61) . The bacterially expressed SWI2/SNF2 protein has a DNA-dependent ATPase but no helicase activity (62) (63) (64) , and mutational studies show that the conserved ATPase domain is necessary for function in vivo (62) (63) (64) (65) . The SWI2/SNF2 protein is contained in a native multisubunit complex of ϳ2 MDa termed SWI/SNF (62, 66) . There is a Drosophila homolog of SWI2/SNF2, brahma (brm), an activator of homeotic genes, as well as two human homologs, BRG1 and HBRM (67) (68) (69) (70) (71) . These homologs are also contained in large multisubunit complexes that contain components related to subunits of yeast SWI/SNF (72) (73) (74) .
How does the SWI/SNF complex counteract the repressive effects of chromatin organization? Because genetic suppressors of SWI2/SNF2 mutants encode histones and nonhistone chromosomal proteins, the SWI/SNF complex is thought to counteract chromatin-mediated, though not exclusively histone-mediated, repression (75) (76) (77) . Biochemical studies show that the complex can directly assist site-specific binding of GAL4 derivatives to a reconstituted mononucleosome in an ATP-dependent manner, alter the pattern of DNase I digestion of a rotationally phased nucleosome (64) , and assist in local disruption within an array of preassembled nucleosomes (78) . A similar alteration of nucleosomes has been observed with human SWI/ SNF, which can also assist transcriptional activators in stimulating an artificially paused RNA polymerase II in reading through downstream nucleosomes (72, 79 -82) . The purified yeast SWI/SNF complex preferentially binds to four-way junction DNA with affinity in the nanomolar range and can introduce positive supercoils into relaxed plasmid DNA, albeit without a requirement for ATP (83) .
Despite these findings, the use of stoichiometric amounts of yeast or mammalian SWI/SNF complex for disrupting nucleosomes in vitro is interesting, as the number of SWI/SNF molecules (estimated to be either ϳ100 or 2000 -4000 molecules/ yeast cell (64, 84) ) is vastly smaller than the ϳ100,000 nucleosomes found in the yeast nucleus. Local concentrations of the complex could be increased as a result of recruitment with the RNA polymerase holoenzyme (84) , but the extent of the association with holoenzyme has been disputed (85) . It is possible that the action of SWI/SNF on chromatin occurs by pathways that are different from the disruption of nucleosome structure revealed in current assays. In this respect, the SWI/ SNF subunit SWI3 is required for transcriptional activation in a Drosophila nuclear extract that was not known to display chromatin assembly (86) .
RSC, NURF, CHD-1-A number of distinct chromatin remodeling complexes have been identified, each of which contains a subunit related to SWI2/SNF2. RSC (remodeling the structure of chromatin) is a highly abundant, 15-component complex isolated from Saccharomyces cerevisiae on the basis of homology to the SWI/SNF complex (85) . RSC contains STH1/ NSP1, a SWI2/SNF2 homolog, as well as homologs of several other SWI/SNF subunits. RSC has DNA-dependent ATPase activity and the ability to alter nucleosome structure in vitro. However, unlike SWI/SNF, RSC is essential for mitotic growth, and whereas its genetic targets remain unknown, the greater abundance of RSC (10 3 -10 4 molecules/cell) suggests that this complex may be globally required for activities such as transcription or replication that involve the remodeling of large numbers of nucleosomes. RSC has not been observed to associate with the RNA polymerase holoenzyme (85) . How the energy of ATP is utilized by SWI2/SNF2, RSC, and other members of the family to perturb nucleosome structure is unclear; a mechanism has been suggested that involves an ATP-driven translocation of the complex on nucleosomal DNA (9, 107) .
The Drosophila nucleosome remodeling factor termed NURF was isolated on the basis of an ATP-dependent requirement for nucleosome disruption in vitro mediated by binding of the Drosophila GAGA transcription factor (87, 88) . NURF is composed of four subunits, one of which (the 140-kDa subunit) is encoded by Drosophila iswi, which shows sequence similarity to the ATPase domain of brm (89, 90) . Unlike SWI/SNF, the ATPase activity of NURF is stimulated significantly more by nucleosomes than by free DNA or by core histones, suggesting that NURF has a unique property of interacting with nucleosomes (88) . Interestingly, substoichiometric levels of NURF (1 NURF:18 nucleosomes) are sufficient to facilitate GAGA factor-mediated nucleosome perturbation. The function of NURF in vivo has not yet been determined. It is possible that the biochemical assays for NURF reflect processes that are separate from or additional to transcription inside the cell.
NURF activity is abundant in chromatin reconstitution extracts derived from Drosophila embryos (91, 92) that are increasingly employed for analyses of the activities of sequencespecific transcription factors in a native chromatin context (87, (93) (94) (95) (96) (97) . In these crude extracts, a number of transcription factors (GAGA factor, HSF, GAL4, Sp1, NF-B, NF-E2, and lac repressor) have been reported to participate in nucleosome disordering and, in several cases, to stimulate transcription manyfold on chromatinized templates. Two other Drosophila chromatin remodeling complexes distinct from NURF have recently been purified. CHRAC (chromatin accessibility complex (98, 108) ) and ACF (ATP-utilizing chromatin assembly and remodeling factor (109)) each possess ATP-dependent activity that can mobilize a nucleosome array to achieve remarkably periodic spacing between nucleosomes. Intriguingly, the ISWI subunit of NURF is also a component of ACF and CHRAC, suggesting that energy harnessed by this common subunit of three remodeling complexes may be transduced in different ways to perturb nucleosome structure.
A putative chromatin remodeling complex, CHD-1, was identified adventitiously as a mammalian DNA-binding protein, which contains three signature sequence motifs: the 52-amino acid chromodomain found in the heterochromatin protein HP-1 and the homeotic repressor Polycomb, the SNF2/SWI2 ATPase domain, and motifs characteristic of minor-groove binding proteins (99, 100) . CHD-1 shows a sequence-selective preference for binding to (A ϩ T)-rich tracts in vitro. Whereas its function as an ATP-dependent nucleosome or chromatin-perturbing complex is undetermined, immunolocalization studies show a striking localization of the protein to the decondensed interbands of polytene chromosomes and to a number of transcriptionally active chromosome puffs (101) , suggesting a link to the process of transcription.
Perspectives
With the emergence of so many new modifiers of chromatin structure comes a long list of outstanding questions that should provide fertile ground for future study. What is the fate of nucleosomal histones during the remodeling process? Are histones partly or fully evicted from DNA, and how might a residual structure promote interactions between DNA binding regulators (102) ? Do nucleosomes that are intrinsically unstable or hyperstable due to the structure of DNA have different requirements for disruption? What roles in chromatin remodeling are performed by architectural DNA-binding proteins such as LEF-1, HMG I(Y), and others (103) and by the RNA polymerase complex itself (104)? Which chromatin modifiers are brought into play for a particular gene and at which step of the activation process: the binding of upstream regulators, assembly of the preinitiation complex, initiation, elongation, or termination? Are ATP-dependent remodeling activities recruited to specific chromosomal sites, or do they diffuse along the chromatin fiber, creating transient windows of opportunity for other factors? When histone-modifying enzymes are recruited by DNA-binding factors, what is the spread of the modification along a nucleosome array, and how is the modification contained? Are the activities of the histone acetyltransferases and histone deacetylases hierarchically integrated with the SWI/ SNF2 family of remodeling machines? How does nucleosome remodeling impact on higher order chromatin folding, or is it regulated by higher order chromatin folding? Answers to these and other questions will surely yield important insights not only for the control of gene expression but also for diverse aspects of chromosome biology.
